3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Uterine Cervical Dysplasia
2
Neoplasms
2
Precancerous Conditions
1
Papilloma
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Interventions
tremelimumab
1
peginterferon alfa-2b
1
Zoledronic Acid
1
Zidovudine
1
Whole-Body Irradiation
1
Valproic Acid
1
Tetradecanoylphorbol Acetate
1
Sodium Chloride
1
Selenium
1
Rosuvastatin Calcium
1
Rituximab
1
Ribavirin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Observation
1
Moxifloxacin
1
Morphine
1
Microarray Analysis
1
Methadone
1
Laser Therapy
1
Interferon alpha-2
1
Infliximab
1
Gene Expression Profiling
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Flow Cytometry
1
Fentanyl
1
Colposcopy
1
Ciprofloxacin
1
Chromatography, High Pressure Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Precancerous Conditions
×
Colposcopy
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled